Cargando…

Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention

OBJECTIVE: To investigate the clinical significance of serum cystatin C (Cys-C) and high-sensitivity C-reactive protein (hs-CRP) in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI). METHODS: One hundred and twenty-eight CHD patients were divided into drug tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Zheng, Li, Li, Ma, Yi, Geng, Xuebin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cirurgia Cardiovascular 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385828/ https://www.ncbi.nlm.nih.gov/pubmed/30810669 http://dx.doi.org/10.21470/1678-9741-2018-0171

Ejemplares similares

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
por: Chen, Runzhen, et al.
Publicado: (2020)

HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis
por: Sun, Lufan, et al.
Publicado: (2019)

Elevated HsCRP in Chronic Obstructive Pulmonary Disease: A Prospective Study of Long-Term Outcomes After Percutaneous Coronary Intervention
por: Zheng, Yitian, et al.
Publicado: (2022)

The relationship between serum levels of hs-CRP and coronary lesion severity
por: RAZBAN, MOHAMMAD MEHDI, et al.
Publicado: (2016)

Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
por: Shang, Da, et al.
Publicado: (2017)

The relationship among angiotensinogen genes polymorphisms and hs‐CRP and coronary artery disease
por: Zhu, Min, et al.
Publicado: (2019)

The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023)

Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9
por: GUO, CHANGLEI, et al.
Publicado: (2014)

Exploring the Association of Fibrinogen and CRP with the Clinical Spectrum of CAD and Periprocedural Outcomes in Patients Undergoing Percutaneous Coronary Interventions
por: Khandelwal, Vijay, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis
por: Assadpour Piranfar, Mohammad
Publicado: (2014)

Non-fasting changes of Hs-CRP level in Chinese patients with coronary heart disease after a daily meal
por: Lin, Qiu-Zhen, et al.
Publicado: (2022)

Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China
por: Li, Jiawen, et al.
Publicado: (2023)

Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease
por: Yaghoubi, Alireza, et al.
Publicado: (2015)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease
por: Wang, Yali, et al.
Publicado: (2021)

Prognostic significance of Troponin I in patients undergoing primary percutaneous coronary intervention
por: Sane, Pratik Sudhir, et al.
Publicado: (2021)

Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB
por: Yang, Yuexia, et al.
Publicado: (2022)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Correlation of clinical features with hs-CRP in TRD patients
por: Qiao, Juan, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
por: Li, Xiaolin, et al.
Publicado: (2020)

Association between the increased level of high-sensitive CRP (hs CRP) and non-arrhythmic ECG changes and echocardiographic abnormalities in patients with acute coronary syndrome
por: Hemmati, Roholla, et al.
Publicado: (2023)

The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment
por: Ozbay, Yilmaz, et al.
Publicado: (2007)

Long-term outcomes of peripheral arterial disease patients with significant coronary artery disease undergoing percutaneous coronary intervention
por: Choi, Byoung Geol, et al.
Publicado: (2021)

Impact of Thrombocytopenia on In-Hospital Outcome in Patients Undergoing Percutaneous Coronary Intervention
por: Chen, Zhongxiu, et al.
Publicado: (2021)

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Tao, Shiyi, et al.
Publicado: (2023)

Diagnostic Impact of Hs-CRP and IL-6 for Acute Coronary Syndrome in Patients Admitted to the ED with Chest Pain: Added Value to the HEART Score?
por: Rafiqi, Khalil, et al.
Publicado: (2023)

Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction
por: MA, YI, et al.
Publicado: (2013)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
por: Tsoulou, Vasiliki, et al.
Publicado: (2023)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention
por: Sun, Hong, et al.
Publicado: (2016)

Prevalence of hs-CRP among Indians with hypertension
por: R, Vasanthii, et al.
Publicado: (2022)

Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Wang, Man, et al.
Publicado: (2023)

Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study
por: Best, Lyle G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o7ueh9gd61miida56jevbuig5e